recombinant human interleukin-2

A drug used to treat melanoma and renal cell carcinoma (a type of kidney cancer) that have spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Recombinant human interleukin-2 is a form of interleukin-2 that is made in the laboratory. Recombinant human interleukin-2 increases the activity and growth of T lymphocytes and B lymphocytes (types of white blood cells). This may help the immune system kill cancer cells. Recombinant human interleukin-2 is a type of biological response modifier. Also called aldesleukin and Proleukin.